Shots:
- Selvita to acquire 100% of the outstanding shares in Fidelta for $37.08M + customary adjustments for net cash & working capital
- The acquisition will expand Selvita’s integrated drug discovery services offering with the addition of Fidelta
- Fidelta will be fully consolidated under Selvita Group & will continue to operate under the Fidelta name. Fidelta will continue to perform drug discovery services for Galapagos for the next five years
Click here to read full press release/ article | Ref: GlobeNewswire | Image: Fidelta
The post Selvita to Acquire Fidelta from Galapagos for ~M first appeared on PharmaShots.
